Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jay David Caplan Insider Profile
4 Followers
Jay David Caplan, President, Chief Product Off at Fractyl Health, Inc., holds 631.16K shares in Fractyl Health, Inc. (Ticker: GUTS).
Jay David Caplan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jay David Caplan's holdings
Insider Roles
President, Chief Product Off
Roles that Jay David Caplan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jay David Caplan
Jay David Caplan's Trading History
List of latest transactions for each holding click on a transaction to see Jay David Caplan's performance on stock
You May Also Like
Jay David Caplan insider profile FAQ
What is the percentage of profitable transactions made by Jay David Caplan?
The percentage of profitable transactions made by Jay David Caplan is ―.
What is the average return per transaction made by Jay David Caplan?
The average return per transaction made by Jay David Caplan is ―.
What stocks does Jay David Caplan hold?
Jay David Caplan holds: GUTS stocks.
What was Jay David Caplan’s latest transaction?
Jay David Caplan latest transaction was an Uninformative Buy of $303.96K.
What was Jay David Caplan's most profitable transaction?
Jay David Caplan’s most profitable transaction was an Informative Sell of GUTS stock on September 13, 2024. The return on the trade was 11.40%.
What is Jay David Caplan's role in Fractyl Health, Inc.?
Jay David Caplan's role in Fractyl Health, Inc. is President, Chief Product Off.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.